EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, HRTX: Heron Therapeutics

02 Oct 26 15:59
LAST:

0.3499

CHANGE:
 0.01		OPEN:
0.3502		HIGH:
0.4050		ASK:
14.0500		VOLUME:
3.78M
CHG(%):
3.18		PREV:
0.3590		LOW:
0.3400		BID:
12.9800		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Oct 260.36000.40500.34000.34764.08M
01 Oct 260.31000.35990.31000.35902.94M
30 Sep 260.30680.34290.30000.31352.47M
29 Sep 260.29180.32000.28570.30603.36M
28 Sep 260.29000.29600.28000.29181.12M
25 Sep 260.29000.30000.28000.29421.57M
24 Sep 260.29680.29890.28000.2900929.8K
23 Sep 260.29800.29960.28470.29101.72M
22 Sep 260.27710.30600.27160.29903.87M
21 Sep 260.31000.31020.26100.27008.59M

PROFILE

Name:Heron Therapeutics
About:Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
Sector:Healthcare
Industry:Biotechnology
Address:100 Regency Forest Drive, Cary, NC, United States, 27518
Website:https://www.herontx.com
CUSIP:00754G102
CIK:0000818033
ISIN:US4277461020
FIGI:BBG000G2GJT7
LEI:549300DR2I1DOPD2IX53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.328.1%
MA10:0.3114.3%
MA20:0.3211.1%
MA50:0.361.9%
MA100:0.4630.7%
MA200:0.80128.3%
STO9:50.09
STO14:57.48
RSI14:59.17
WPR14:-12.81 
MTM14:0.03
ROC14:0.11 
ATR:0.03 
Week High:0.4115.7%
Week Low:0.2825.0%
Month High:0.4115.7%
Month Low:0.26128.3%
Year High:1.58350.1%
Year Low:0.2634.1%

RECENT SPLITS

Date Ratio
13 Jan 20141-20
25 May 20071-4